Skip to main content

Nabriva Therapeutics plc (NASDAQ: NBRV) Investor Securities Class Action Lawsuit 05/09/2019

  • You must submit the settlement Proof form attached below, in order to participate in this settlement. There is a strict deadline of April 30, 2021 by which all claims must be submitted. The instructions for submitting are included in the Proof and the Notice files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOLDERS FOUNDATION, INC.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 28, 2021 - The court preliminarily approved the settlement. December 7, 2020 - A stipulation of settlement was filed by the parties. June 24, 2020 - A consolidated second amended complaint was filed. April 28, 2020 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. November 26, 2019 - A motion to dismiss the consolida...



You must register (for free) or login to view the entire case.